Search Results 681-690 of 16347 for pharmacogenetics
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Giving chemotherapy before a stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. Giving colony-stimulating ...
Rochester, Minn. The aim of this study is to develop a feasible, acceptable, and sustainable comprehensive cancer distress management program that is tailored ...
With obesity comes an increasing risk of cardiovascular disease, including stroke, congestive heart failure and myocardial infarction.
The purpose of this study is to see how changes in the amount of oxygen breathed can affect how the body responds to changes in blood sugar. Participation ...
In January of 2017, the Cytogenetics Laboratory and Molecular Genetics Laboratory combined to form one laboratory now known as the Genomics Laboratory. To ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Trailblazing exposome researchers take center stage at Mayo Clinic's Individualizing Medicine Conference featured image · Advances in treating pancreatic cancer ...
Narrator: For 12 years, this is the routine that Pete Giannaris has had to accept, kidney dialysis three times a week. As vital as it is, he admits it can ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.